Type to search


AstraZeneca selling U.S. headquarters in Fairfax


AstraZeneca is selling its nearly 30-acre U.S. headquarters campus in Fairfax, but not necessarily moving, according to a News Journal report.

The newspaper said sources familiar with the offering said he company wants to sell the campus and lease it back from the new owner.

Spokesperson Abigail Bozrath said the company is considering all of its options, including redeveloping the site. “In order to fully explore this [redevelopment] possibility, AstraZeneca will be soliciting bids from real estate developers in the coming months and that requires us putting the site on the market for sale,” she said.

JLL, the Chicago real estate company that handles all AstraZeneca’s sales and acquisitions, is listing the property, according to a spokeswoman for the Chicago realtor. In May, AstraZeneca announced it might leave the Fairfax campus but pledged it would remain in Delaware.

AstraZeneca has about 2,100 workers in Fairfax and Newark.

Get the free DBT email newsletter  

Follow the people, companies and issues that matter most to business in Delaware.


You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Get the DBT Book of Lists

The definitive publication of contacts and key information from over 1,500 of Delaware's top businesses and organizations across 60 industries. 

No, thank you.

Free for a limited time! (Normally $50)

Stay updated with our free email newsletter

Keep up with the issues, companies and people that matter most to business in Delaware.

No, thank you.